Ring constrained analogues of beta-alanine-containing GPIIb/IIIa receptor antagonists |
| |
| Authors: | Sielecki T M Wityak J Liu J Mousa S A Thoolen M Wexler R R Olson R E |
| |
| Institution: | DuPont Pharmaceuticals Company, Experimental Station, Wilmington, DE 19880-0500, USA. thais.m.sielecki@dupont.harma.com |
| |
| Abstract: | A series of ring constrained analogues of the GPIIb/IIIa receptor antagonist XR299 (1) was investigated as potential inhibitors of glycoprotein IIb/IIIa, a platelet receptor that plays a key role in platelet aggregation and platelet adhesion. Ring size was found to have a large effect on in vitro potency. Selected compounds showed good in vitro activity, a preference for binding to activated platelets, and modest duration of action when dosed i.v. as a racemate in a canine model. |
| |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ |
|
